Skye Bioscience, Inc. (SKYE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 29.74M |
| Enterprise Value | 24.13M |
| P/E Ratio | -0.22 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -22.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.04 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.58 |
| Return On Equity | -3.29 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -723,352 |
| EBITDA | -55.2M |
| Net Income | -55.92M |
| Diluted EPS | -1.41 |
| Total Cash | 10.06M |
| Total Cash/Share | 0.25 |
| Total Debt | 35,696 |
| Total Debt/Equity | -0.07 |
| Current Ratio | 0.95 |
| Book Value Per Share | -0.01 |
| 52-Week Change | -92.09 |
| 52-Week High | 39.92 |
| 52-Week Low | 0.26 |
| Moving Average 50 Days | 4.87 |
| Moving Average 200 Days | 6.47 |
| Average Volume | 61,055 |
| Shares Outstanding | 35.14M |
| % Held by Institutions | 40.39 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | August 24, 2026 |